Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CN Bio
Cambridge, England, United Kingdomcn-bio.com ↗
- Ownership
- Private
- Employees
- ~63
- Development stage
- Commercial
01
Overview
CN Bio develops organ-on-a-chip microphysiological systems that enable researchers to generate human-relevant efficacy and safety data for drug discovery. Their PhysioMimix® system has been recognized by the FDA as a valuable tool for predicting human responses to drugs, supporting regulatory submissions such as Inipharm’s INI‑822 application. The company’s platforms are used globally by pharmaceutical companies to improve preclinical predictivity and reduce reliance on animal models.
- Therapeutic areas
- GastroenterologyMetabolic DisordersOther
- Modalities
- Small molecule (supported in platform)Monoclonal antibody (supported in platform)Oligonucleotide (supported in platform)Biologic (supported in platform)Device (organ-on-a-chip systems)
- Industry
- Non-Drug Biotech
02
Partnerships
Pharmaron – strategic global R&D partnership to validate and expand OOC applicationsAltis Biosystems – partnership to develop next-generation gut/liver microphysiological systems for advanced ADME studiesLifeNet Health LifeSciences – distribution agreement for primary human cells supplyLonza – distribution agreement for hepatocytesUS FDA Center for Drug Evaluation & Research – collaborative evaluation of OOC technologies
Beyond the preview
Go deeper on CN Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CN Bio.